task_id stringlengths 30 65 | persona stringclasses 2
values | occupation stringclasses 7
values | aspect stringlengths 30 53 | doc_id stringlengths 9 36 | document_name stringlengths 6 142 | document_file stringlengths 13 40 | document pdf | doc_pages int32 5 27 | case_setup stringlengths 602 1.72k | task_prompt stringlengths 1.92k 3.82k | sub_questions listlengths 3 8 | anchors listlengths 4 17 | rubric listlengths 38 77 | n_subquestions int32 3 8 | n_criteria int32 38 77 | difficulty_band stringclasses 5
values | n_models_solved int32 0 6 | n_models_all_criteria int32 0 4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
generalist_clinician/emergency_medicine_physicians/task_04 | generalist_clinician | emergency_medicine_physicians | Treatment & Pharmacologic Management | cdc:78278 | Measuring Appropriate Antimicrobial Use: Attempts at Opening the Black Box | cdc_78278.pdf | 13 | An emergency medicine physician is completing an antimicrobial stewardship review of several recent ED encounters flagged by pharmacy. The cases include:
(1) A patient started on empiric IV vancomycin plus cefepime for suspected sepsis whose blood cultures now grow ampicillin-susceptible E. coli. The patient has norma... | An emergency medicine physician is completing an antimicrobial stewardship review of several recent ED encounters flagged by pharmacy. The cases include:
(1) A patient started on empiric IV vancomycin plus cefepime for suspected sepsis whose blood cultures now grow ampicillin-susceptible E. coli. The patient has norma... | [
{
"q_no": 1,
"question": "For Case 1 (empiric vancomycin plus cefepime, now with blood cultures growing ampicillin-susceptible E. coli in a patient with normal renal function): using the document's Table 2 definitions, classify (a) the continued use of vancomycin and (b) the continued use of cefepime. For e... | [
{
"id": "a1",
"element_type": "criteria",
"title": "Table 2. Proposed definitions of terminology to describe a day of therapy with a particular antimicrobial agent — Unnecessary",
"locator_quote": "Treating community-acquired pneumonia for 14 days instead of 5–7",
"page": 13,
"answer_bearing... | [
{
"rubric_id": "task_04-q1-01",
"q_no": 1,
"tier": "G4 Task",
"grading_mode": "match",
"kind": "retrieval",
"criterion": "Cites Table 2's Unnecessary-use definition, including that continuation of empiric broad-spectrum therapy after cultures reveal the infecting pathogen qualifies as Unnece... | 7 | 77 | unsolved | 0 | 0 | |
generalist_clinician/family_medicine_physicians/task_06 | generalist_clinician | family_medicine_physicians | Care Coordination and Referral | cdc:149648 | TRANSITIONAL CARE COORDINATION (TCC): NEW YORK CITY | cdc_149648.pdf | 5 | You are a family medicine physician serving as medical director for a Transitional Care Coordination (TCC) program for people with HIV in NYC jails. You are reviewing Mr. R, a 34-year-old man with HIV incarcerated at Rikers on a non-violent charge, expected to be released in approximately 4 months. Mr. R has told the j... | You are a family medicine physician serving as medical director for a Transitional Care Coordination (TCC) program for people with HIV in NYC jails. You are reviewing Mr. R, a 34-year-old man with HIV incarcerated at Rikers on a non-violent charge, expected to be released in approximately 4 months. Mr. R has told the j... | [
{
"q_no": 1,
"question": "Using the program manual, determine whether Mr. R qualifies for enrollment in the TCC program. Walk through each program criterion against his profile and give an include/exclude decision.",
"reference_answer": "Include. Mr. R meets all four eligibility criteria: he is incarcer... | [
{
"id": "a1",
"element_type": "value",
"title": "Structural Components – Access – HIV health care",
"locator_quote": "Provided a 7-day supply of ART medication and 21-day prescriptions",
"page": 2,
"answer_bearing": true
},
{
"id": "a2",
"element_type": "enumeration",
"title"... | [
{
"rubric_id": "task_06-q1-01",
"q_no": 1,
"tier": "G4 Task",
"grading_mode": "match",
"kind": "retrieval",
"criterion": "Surfaces the eligibility criteria from the program manual: incarcerated in a NYC jail, likely release within 6 months, age ≥18, and willing to receive HIV medical care.",... | 5 | 63 | unsolved | 0 | 0 | |
generalist_clinician/family_medicine_physicians/task_08 | generalist_clinician | family_medicine_physicians | Patient Information Management | cdc:256051 | State Variation in Electronic Sharing of Information in Physician Offices: United States, 2015 | cdc_256051.pdf | 8 | Dr. Chen is a family medicine physician practicing in Wisconsin. She is preparing an internal practice-improvement report on her clinic's interoperability performance and is using the NCHS Data Brief No. 261 (October 2016), 'State Variation in Electronic Sharing of Information in Physician Offices: United States, 2015,... | Dr. Chen is a family medicine physician practicing in Wisconsin. She is preparing an internal practice-improvement report on her clinic's interoperability performance and is using the NCHS Data Brief No. 261 (October 2016), 'State Variation in Electronic Sharing of Information in Physician Offices: United States, 2015,... | [
{
"q_no": 1,
"question": "For the national benchmark section of the report, what percentage figure from the data brief should Dr. Chen cite as the 2015 rate for office-based physicians who electronically integrated patient health information from other providers?",
"reference_answer": "31.1%",
"task... | [
{
"id": "a1",
"element_type": "enumeration",
"title": "Figure 1. Percentage of office-based physicians who sent, received, integrated, or searched for patient health information electronically: United States, 2015",
"locator_quote": "electronically sent (38.2%), received (38.3%), integrated (31.1%),... | [
{
"rubric_id": "task_08-q1-01",
"q_no": 1,
"tier": "G4 Task",
"grading_mode": "match",
"kind": "retrieval",
"criterion": "Extracts from Figure 1 the 2015 percentage for the 'integrated' activity: 31.1%.",
"source_type": "premise",
"source_anchor_id": "a1",
"task_types": [
"... | 6 | 49 | unsolved | 0 | 0 | |
generalist_clinician/family_medicine_physicians/task_11 | generalist_clinician | family_medicine_physicians | Population Health Program Administration | cdc:77843 | Necessary Infrastructure of Infection Prevention and Healthcare Epidemiology Programs: A Review | cdc_77843.pdf | 18 | Dr. Reyes, a family medicine physician, has been appointed medical director of infection prevention and control (IPC) program development at a newly consolidated health system. Her immediate charge concerns the flagship site: a community-based hospital with 340 beds, 55 ICU beds, and approximately 60,000 annual admissi... | Dr. Reyes, a family medicine physician, has been appointed medical director of infection prevention and control (IPC) program development at a newly consolidated health system. Her immediate charge concerns the flagship site: a community-based hospital with 340 beds, 55 ICU beds, and approximately 60,000 annual admissi... | [
{
"q_no": 1,
"question": "Using the guidance document, determine the recommended physician healthcare epidemiologist/medical director staffing commitment for this facility. First, apply the facility-size–based recommendation table for the healthcare epidemiologist/medical director role. Then, separately app... | [
{
"id": "a1",
"element_type": "table",
"title": "TABLE 2. Healthcare Epidemiologist/Medical Director–Recommended Resource Allocation",
"locator_quote": "≥1.5 FTE of full professor salary (based on AAMC salary compensation)",
"page": 17,
"answer_bearing": true
},
{
"id": "a2",
"el... | [
{
"rubric_id": "task_11-q1-01",
"q_no": 1,
"tier": "G4 Task",
"grading_mode": "match",
"kind": "retrieval",
"criterion": "Retrieves from Table 2 that community-based hospitals with ≥300 beds and/or ≥50 ICU beds warrant ≥1.0 FTE salary of regional market value toward infection control.",
... | 3 | 44 | mid | 3 | 2 | |
generalist_clinician/general_internal_medicine_physicians/task_01 | generalist_clinician | general_internal_medicine_physicians | Diagnostic Assessment & Evaluation | cdc:85393 | Morbidity and Mortality Weekly Report (MMWR): Recommendations and Reports / Vol. 68 / No. 5, January 3, 2020 | cdc_85393.pdf | 24 | A 28-year-old woman presents to your general internal medicine clinic for a same-day STD evaluation. Over the past three months she has had a new sexual partner. She reports receptive anal intercourse with inconsistent condom use. She describes intermittent rectal discomfort with mucoid anal discharge. She brings recor... | A 28-year-old woman presents to your general internal medicine clinic for a same-day STD evaluation. Over the past three months she has had a new sexual partner. She reports receptive anal intercourse with inconsistent condom use. She describes intermittent rectal discomfort with mucoid anal discharge. She brings recor... | [
{
"q_no": 1,
"question": "Before you touch the patient, outline the sequence of phases your STD evaluation visit should follow today (from initial interview through send-out testing), and, for the opening interview phase, list every required content component of the sexual history you must document.",
"... | [
{
"id": "a1",
"element_type": "enumeration",
"title": "Sexual History and Physical Examination — five Ps",
"locator_quote": "the five Ps (i.e., partners, practices, protection, past history of STDs, and prevention of pregnancy)",
"page": 6,
"answer_bearing": true
},
{
"id": "a2",
... | [
{
"rubric_id": "task_01-q1-01",
"q_no": 1,
"tier": "G4 Task",
"grading_mode": "match",
"kind": "retrieval",
"criterion": "Surfaces the document fact that a complete sexual history includes inquiring about the five Ps: partners, practices, protection, past history of STDs, and prevention of p... | 7 | 66 | mid | 3 | 0 | |
generalist_clinician/general_internal_medicine_physicians/task_03 | generalist_clinician | general_internal_medicine_physicians | Interprofessional Consultation & Care Coordination | cdc:149593 | HIV CARE COORDINATION PROGRAM (CCP) | cdc_149593.pdf | 7 | Dr. M is a general internist at a primary care clinic in the New York City eligible metropolitan area. She is seeing two patients today whose care she wants to coordinate with the NYC Ryan White Part A HIV Care Coordination Program (CCP).
Patient 1 (index patient): A 34-year-old man who resides in Brooklyn, NY. He was... | Dr. M is a general internist at a primary care clinic in the New York City eligible metropolitan area. She is seeing two patients today whose care she wants to coordinate with the NYC Ryan White Part A HIV Care Coordination Program (CCP).
Patient 1 (index patient): A 34-year-old man who resides in Brooklyn, NY. He was... | [
{
"q_no": 1,
"question": "Using the document, decide whether the index patient (Patient 1) meets the criteria to be enrolled in the CCP evaluation study's target population, and explain which specific operational thresholds gate that enrollment decision that are NOT stated in the programmatic 'Intended Popu... | [
{
"id": "a1",
"element_type": "enumeration",
"title": "Intended Population",
"locator_quote": "Newly diagnosed, New to HIV care, Out of HIV care, New to HIV treatment",
"page": 1,
"answer_bearing": true
},
{
"id": "a2",
"element_type": "enumeration",
"title": "Brief Descripti... | [
{
"rubric_id": "task_03-q1-01",
"q_no": 1,
"tier": "G4 Task",
"grading_mode": "match",
"kind": "retrieval",
"criterion": "States that the Intended Population enumeration includes no geographic or income eligibility criteria.",
"source_type": "premise",
"source_anchor_id": "a1",
"... | 4 | 54 | ceiling | 6 | 1 | |
generalist_clinician/general_internal_medicine_physicians/task_04 | generalist_clinician | general_internal_medicine_physicians | Interprofessional Consultation & Care Coordination | cdc:149401 | LA LINKS (LOUISIANA LINKS) | cdc_149401.pdf | 6 | Dr. M is a general internist at a primary care clinic in New Orleans, Louisiana. She is reviewing two established patients with HIV before her afternoon visits and is considering whether to refer them to the Louisiana Links (LA Links) Linkage-to-Care Coordinator program described in a CDC compendium chapter she has pul... | Dr. M is a general internist at a primary care clinic in New Orleans, Louisiana. She is reviewing two established patients with HIV before her afternoon visits and is considering whether to refer them to the Louisiana Links (LA Links) Linkage-to-Care Coordinator program described in a CDC compendium chapter she has pul... | [
{
"q_no": 1,
"question": "For Patient A, applying both the clinical/diagnostic criteria and the geographic/surveillance criteria that the LA Links chapter uses to define who the program is intended for and who is eligible, does she qualify for an LA Links referral? Justify your yes/no determination against ... | [
{
"id": "a1",
"element_type": "criteria",
"title": "Intended Population",
"locator_quote": "received a new HIV diagnosis (6-12 months after diagnosis and have no CD4 T-cell or viral load test)",
"page": 1,
"answer_bearing": true
},
{
"id": "a2",
"element_type": "branching_rule",
... | [
{
"rubric_id": "task_04-q1-01",
"q_no": 1,
"tier": "G4 Task",
"grading_mode": "match",
"kind": "retrieval",
"criterion": "Identifies the clinical/diagnostic intended-population criterion: a new HIV diagnosis 6–12 months prior.",
"source_type": "premise",
"source_anchor_id": "a1",
... | 7 | 74 | unsolved | 0 | 0 | |
generalist_clinician/general_internal_medicine_physicians/task_08 | generalist_clinician | general_internal_medicine_physicians | Population & Preventive Health Program Administration | cdc:251745 | National Diabetes Prevention Program: Promoting the [Name of Program]: Tips and resources for community health workers and community champions | cdc_251745.pdf | 15 | Dr. Patel is medical director of a hospital-affiliated CDC-recognized Diabetes Prevention Program that is also enrolled as an MDPP supplier. In her population-health clinic she is evaluating Mrs. Chen, a 62-year-old Asian American woman. Mrs. Chen has Medicare Part B through Original Medicare (Fee-for-Service). Her BMI... | Dr. Patel is medical director of a hospital-affiliated CDC-recognized Diabetes Prevention Program that is also enrolled as an MDPP supplier. In her population-health clinic she is evaluating Mrs. Chen, a 62-year-old Asian American woman. Mrs. Chen has Medicare Part B through Original Medicare (Fee-for-Service). Her BMI... | [
{
"q_no": 1,
"question": "Using the operations manual, determine whether Mrs. Chen meets the criteria for referral to a type 2 diabetes prevention program. Cite each criterion and state whether her profile satisfies or fails it.",
"reference_answer": "Mrs. Chen is eligible for referral. She meets every ... | [
{
"id": "a1",
"element_type": "criteria",
"title": "Who is eligible for referral to a type 2 diabetes prevention program?",
"locator_quote": "Have a body mass index (BMI) of ≥25 kg/m2 (BMI≥23 kg/m2 if Asian American)",
"page": 12,
"answer_bearing": true
},
{
"id": "a2",
"element_... | [
{
"rubric_id": "task_08-q1-01",
"q_no": 1,
"tier": "G4 Task",
"grading_mode": "match",
"kind": "retrieval",
"criterion": "Surfaces the four DPP eligibility criteria from the operations manual: age, BMI (with Asian American variant), qualifying blood test/gestational diabetes/CDC screening re... | 5 | 67 | hard | 2 | 0 | |
generalist_clinician/nurse_practitioners/task_02 | generalist_clinician | nurse_practitioners | Care Coordination & Patient Navigation | cdc:149598 | ACCESS NY PATIENT NAVIGATION PROGRAM | cdc_149598.pdf | 5 | You are an NP at an Amida Care–affiliated HIV clinic reviewing a new patient navigation referral. The member is a 34-year-old woman with HIV who enrolled in Amida Care 60 days ago and has no designated HIV specialist on file. Her most recent HIV primary care claim was 312 days ago at a prior clinic; the visit immediate... | You are an NP at an Amida Care–affiliated HIV clinic reviewing a new patient navigation referral. The member is a 34-year-old woman with HIV who enrolled in Amida Care 60 days ago and has no designated HIV specialist on file. Her most recent HIV primary care claim was 312 days ago at a prior clinic; the visit immediate... | [
{
"q_no": 1,
"question": "Using the program's eligibility definitions and its retention definition, determine (a) which eligibility path (if any) the member qualifies under for enrollment in the navigation program, and (b) based on her two most recent HIV primary care visit dates, whether she would meet the... | [
{
"id": "a1",
"element_type": "criteria",
"title": "Intended Population",
"locator_quote": "People with HIV enrolled in the Amida Care health plan who were never in care or lost to care",
"page": 1,
"answer_bearing": true
},
{
"id": "a2",
"element_type": "branching_rule",
"ti... | [
{
"rubric_id": "task_02-q1-01",
"q_no": 1,
"tier": "G4 Task",
"grading_mode": "match",
"kind": "retrieval",
"criterion": "Surfaces the intended-population definition (a1): people with HIV enrolled in the Amida Care health plan who were never in care or lost to care.",
"source_type": "pre... | 6 | 73 | unsolved | 0 | 0 | |
generalist_clinician/nurse_practitioners/task_07 | generalist_clinician | nurse_practitioners | Diagnosis & Clinical Assessment | cdc:84248 | Equivalency of the diagnostic accuracy of the PHQ-8 and PHQ-9: A systematic review and individual participant data meta-analysis | cdc_84248.pdf | 27 | An adult primary care NP is setting up a depression screening protocol and reviews this PHQ validation document. This morning she screens a 42-year-old woman whose PHQ-9 total score is 16, with Item 9 endorsed at a rating of '1' (several days). The clinic's validation program benchmarks its screening tool against the M... | An adult primary care NP is setting up a depression screening protocol and reviews this PHQ validation document. This morning she screens a 42-year-old woman whose PHQ-9 total score is 16, with Item 9 endorsed at a rating of '1' (several days). The clinic's validation program benchmarks its screening tool against the M... | [
{
"q_no": 1,
"question": "Using the document, what is the standard PHQ-9 total-score cutoff used to identify probable major depression in adult screening, and where in the document is this stated?",
"reference_answer": "A PHQ-9 score of 10 or greater is the standard cutoff for screening to identify prob... | [
{
"id": "a1",
"element_type": "threshold",
"title": "Standard PHQ-9 cutoff for major depression screening",
"locator_quote": "standard cutoff of a score of 10 or greater",
"page": 5,
"answer_bearing": true
},
{
"id": "a2",
"element_type": "value",
"title": "PHQ-8 vs PHQ-9 sen... | [
{
"rubric_id": "task_07-q1-01",
"q_no": 1,
"tier": "G4 Task",
"grading_mode": "match",
"kind": "retrieval",
"criterion": "Retrieves from the document that the PHQ-9 uses a standard cutoff of a score of 10 or greater to identify people who may have depression (p.5, Introduction).",
"sourc... | 7 | 55 | easy | 5 | 0 | |
generalist_clinician/nurse_practitioners/task_09 | generalist_clinician | nurse_practitioners | Professional Practice, Regulation & Advocacy | cdc:79132 | Prevalence of Antimicrobial Use and Opportunities to Improve Prescribing Practices in U.S. Nursing Homes | cdc_79132.pdf | 6 | A nurse practitioner serves on the quality and antibiotic stewardship committee at a 120-bed nursing home and is preparing a CDC Core Elements–aligned stewardship audit. She is using the JAMDA point-prevalence study on antimicrobial use in U.S. nursing homes (Thompson et al.) to (1) benchmark her facility's antimicrobi... | A nurse practitioner serves on the quality and antibiotic stewardship committee at a 120-bed nursing home and is preparing a CDC Core Elements–aligned stewardship audit. She is using the JAMDA point-prevalence study on antimicrobial use in U.S. nursing homes (Thompson et al.) to (1) benchmark her facility's antimicrobi... | [
{
"q_no": 1,
"question": "What overall point-prevalence rate of antimicrobial use among nursing-home residents (with its 95% confidence interval) should the NP cite from the study as the national benchmark for her facility?",
"reference_answer": "11.1% (95% CI 9.4%–12.9%).",
"task_types": [
"T... | [
{
"id": "a1",
"element_type": "value",
"title": "Results - Overall AU prevalence",
"locator_quote": "AU prevalence was 11.1% (95% confidence interval, 9.4%-12.9%)",
"page": 3,
"answer_bearing": true
},
{
"id": "a2",
"element_type": "table",
"title": "Table 1. Resident Charact... | [
{
"rubric_id": "task_09-q1-01",
"q_no": 1,
"tier": "G4 Task",
"grading_mode": "match",
"kind": "retrieval",
"criterion": "Retrieves from the study that overall AU prevalence was 11.1% with 95% CI 9.4%–12.9%.",
"source_type": "premise",
"source_anchor_id": "a1",
"task_types": [
... | 8 | 65 | hard | 1 | 0 | |
generalist_clinician/nurse_practitioners/task_10 | generalist_clinician | nurse_practitioners | Treatment Planning & Prescribing | cdc:78412 | Advances in optimizing antibiotic prescribing in outpatient settings | cdc_78412.pdf | 27 | You are an NP at a community primary-care clinic seeing two patients back-to-back on a busy afternoon. You have pulled up the outpatient antibiotic stewardship guideline.
Patient A: 34-year-old man with 8 days of facial pressure, purulent nasal discharge, and mild fever consistent with uncomplicated acute bacterial si... | You are an NP at a community primary-care clinic seeing two patients back-to-back on a busy afternoon. You have pulled up the outpatient antibiotic stewardship guideline.
Patient A: 34-year-old man with 8 days of facial pressure, purulent nasal discharge, and mild fever consistent with uncomplicated acute bacterial si... | [
{
"q_no": 1,
"question": "Patient A asks specifically about the 10-day course his friend received for sinusitis. Using the guideline, what duration of antibiotic therapy is appropriate for his uncomplicated acute sinusitis, and how does that compare with what he is requesting?",
"reference_answer": "The... | [
{
"id": "a1",
"element_type": "value",
"title": "US outpatient antibiotic prescribing - sinusitis duration",
"locator_quote": "longer than the guideline-recommended 5–7 days of antibiotic therapy for uncomplicated cases",
"page": 5,
"answer_bearing": true
},
{
"id": "a2",
"elemen... | [
{
"rubric_id": "task_10-q1-01",
"q_no": 1,
"tier": "G4 Task",
"grading_mode": "match",
"kind": "retrieval",
"criterion": "States that the guideline-recommended antibiotic duration for uncomplicated adult acute sinusitis is 5–7 days.",
"source_type": "premise",
"source_anchor_id": "a1... | 5 | 49 | ceiling | 6 | 0 | |
generalist_clinician/physician_assistants/task_02 | generalist_clinician | physician_assistants | Clinical Supply & Resource Management | cdc:182963 | Infection Prevention and Control for Ebola in Health Care Settings – West Africa and United States | cdc_182963.pdf | 8 | You are a physician assistant serving as the clinical supply and infection prevention & control (IPC) lead at a U.S. community hospital that has been designated as an Ebola assessment hospital (not an Ebola treatment center). A traveler recently returned from West Africa presents to your emergency department with fever... | You are a physician assistant serving as the clinical supply and infection prevention & control (IPC) lead at a U.S. community hospital that has been designated as an Ebola assessment hospital (not an Ebola treatment center). A traveler recently returned from West Africa presents to your emergency department with fever... | [
{
"q_no": 1,
"question": "Your staff were trained on the summer 2014 CDC Ebola PPE recommendations. Compared with that earlier version, what specific procedural requirements (beyond the PPE items themselves) did the subsequent fall 2014 CDC update introduce that your team must now meet?",
"reference_ans... | [
{
"id": "a1",
"element_type": "enumeration",
"title": "Developing Ebola IPC Guidance for U.S. Health Care Facilities — initial recommended PPE (August 2014)",
"locator_quote": "the recommended PPE for Ebola patient care was a gown, gloves, eye protection, and facemask",
"page": 4,
"answer_be... | [
{
"rubric_id": "task_02-q1-01",
"q_no": 1,
"tier": "G4 Task",
"grading_mode": "match",
"kind": "retrieval",
"criterion": "States the August 2014 baseline recommended PPE as gown, gloves, eye protection, and facemask.",
"source_type": "premise",
"source_anchor_id": "a1",
"task_typ... | 4 | 38 | unsolved | 0 | 0 | |
generalist_clinician/physician_assistants/task_04 | generalist_clinician | physician_assistants | Treatment Planning & Prescribing | cdc:42418 | Morbidity and Mortality Weekly Report (MMWR): Recommendations and Reports / Vol. 65 / No. 6, November 11, 2016 | cdc_42418.pdf | 16 | A physician assistant in a busy outpatient clinic is working through a morning session and consults the CDC's Core Elements of Outpatient Antibiotic Stewardship (MMWR Recomm Rep 2016;65[No. 6]) to guide several decisions. Three encounters and one administrative task are queued:
1) A previously healthy 34-year-old adul... | A physician assistant in a busy outpatient clinic is working through a morning session and consults the CDC's Core Elements of Outpatient Antibiotic Stewardship (MMWR Recomm Rep 2016;65[No. 6]) to guide several decisions. Three encounters and one administrative task are queued:
1) A previously healthy 34-year-old adul... | [
{
"q_no": 1,
"question": "For the stewardship summary requested by the supervising physician, what national numeric reduction target and target year for inappropriate outpatient antibiotic use does the CDC document cite, and what current baseline figure for unnecessary outpatient antibiotic prescribing does... | [
{
"id": "a1",
"element_type": "enumeration",
"title": "Box 2: High-priority conditions - overprescribed (antibiotics not indicated)",
"locator_quote": "antibiotics are not indicated (e.g., acute bronchitis, nonspecific upper respiratory infection, or viral pharyngitis)",
"page": 5,
"answer_b... | [
{
"rubric_id": "task_04-q1-01",
"q_no": 1,
"tier": "G4 Task",
"grading_mode": "match",
"kind": "retrieval",
"criterion": "Surfaces the national target from a11: reduce inappropriate antibiotic use by 50% for monitored conditions in outpatient settings by 2020.",
"source_type": "premise",... | 6 | 64 | hard | 2 | 0 | |
pharmacist/pharmacists/task_06 | pharmacist | pharmacists | Prescription Review and Verification | eb09c632-ad0b-4dc9-b7a6-3189ba25f77e | Naltrexone | eb09c632-ad0b-4dc9-b7a6-3189ba25f77e.pdf | 16 | A pharmacist receives a new prescription for extended-release naltrexone (Vivitrol) 380 mg IM for a 34-year-old male patient. The referring order lists a diagnosis of opioid dependence following completion of detoxification, and requests a single monthly injection. On chart review, the patient reports his last use of a... | A pharmacist receives a new prescription for extended-release naltrexone (Vivitrol) 380 mg IM for a 34-year-old male patient. The referring order lists a diagnosis of opioid dependence following completion of detoxification, and requests a single monthly injection. On chart review, the patient reports his last use of a... | [
{
"q_no": 1,
"question": "For this product, what does the prescribing information state as the recommended dose, route, and frequency of administration? Report each component exactly as stated.",
"reference_answer": "Recommended dose 380 mg, delivered intramuscularly (deep) as a gluteal injection, every... | [
{
"id": "a1",
"element_type": "criteria",
"title": "1.1 Alcohol Dependence Indication",
"locator_quote": "indicated for the treatment of alcohol dependence in patients who are able to abstain",
"page": 1,
"answer_bearing": true
},
{
"id": "a2",
"element_type": "criteria",
"ti... | [
{
"rubric_id": "task_06-q1-01",
"q_no": 1,
"tier": "G4 Task",
"grading_mode": "match",
"kind": "retrieval",
"criterion": "Surfaces from §2.1 the stated injection-site rotation instruction: alternate buttocks (gluteal injection) for each subsequent injection.",
"source_type": "premise",
... | 8 | 72 | mid | 3 | 0 | |
pharmacist/pharmacists/task_08 | pharmacist | pharmacists | Prescription Review and Verification | d5de6772-699a-46a0-a3c6-b4be83caff14 | PANTOPRAZOLE SODIUM | d5de6772-699a-46a0-a3c6-b4be83caff14.pdf | 13 | A hospital pharmacist reviews a newly written IV pantoprazole order for a 54-year-old adult inpatient with confirmed Zollinger-Ellison syndrome. The order reads: pantoprazole 80 mg IV every 8 hours for 7 days, to be administered by IV push. The pharmacy note attached to the order asks the pharmacist to (a) select the a... | A hospital pharmacist reviews a newly written IV pantoprazole order for a 54-year-old adult inpatient with confirmed Zollinger-Ellison syndrome. The order reads: pantoprazole 80 mg IV every 8 hours for 7 days, to be administered by IV push. The pharmacy note attached to the order asks the pharmacist to (a) select the a... | [
{
"q_no": 1,
"question": "Based on the patient's documented indication, which of the two indication-specific adult dosing pathways in the prescribing information applies to this order? Identify the indication branch and state the corresponding recommended dosing pathway the labeling assigns to it.",
"re... | [
{
"id": "a1",
"element_type": "criteria",
"title": "1.1 GERD Associated with a History of Erosive Esophagitis",
"locator_quote": "indicated for short-term treatment (7 to 10 days) of adult patients with gastroesophageal reflux disease",
"page": 1,
"answer_bearing": true
},
{
"id": "a... | [
{
"rubric_id": "task_08-q1-01",
"q_no": 1,
"tier": "G4 Task",
"grading_mode": "match",
"kind": "retrieval",
"criterion": "Surfaces the labeled indication that Section 1.2 covers pathological hypersecretory conditions including Zollinger-Ellison (ZE) Syndrome in adults.",
"source_type": "... | 6 | 59 | ceiling | 6 | 0 | |
pharmacist/pharmacists/task_10 | pharmacist | pharmacists | Medication Quality and Chemical Analysis | c5f1da6b-9b01-4814-97a5-3d7efbedec9c | CLINIMIX E | c5f1da6b-9b01-4814-97a5-3d7efbedec9c.pdf | 9 | A hospital pharmacist reviews a physician's order to start parenteral nutrition with CLINIMIX E 5/15 (5% amino acid in 15% dextrose) for an inpatient who is a 3 kg neonate. The order proposes administration via a peripheral vein. The formulary also stocks an 8/14 central-only formulation, but the order is for 5/15. The... | A hospital pharmacist reviews a physician's order to start parenteral nutrition with CLINIMIX E 5/15 (5% amino acid in 15% dextrose) for an inpatient who is a 3 kg neonate. The order proposes administration via a peripheral vein. The formulary also stocks an 8/14 central-only formulation, but the order is for 5/15. The... | [
{
"q_no": 1,
"question": "For the CLINIMIX E 5/15 strength ordered, report the calculated osmolarity (in mOsmol/L) and the total caloric content (in kcal/L) of the finished product as given in the product's composition table.",
"reference_answer": "For CLINIMIX E 5/15: calculated osmolarity = 1395 mOsmo... | [
{
"id": "a1",
"element_type": "table",
"title": "Table 7: INGREDIENTS PER 100mL OF CLINIMIX E",
"locator_quote": "Dextrose Hydrous, USP (g/100 mL) 5 5 10 15 20 10 14",
"page": 4,
"answer_bearing": true
},
{
"id": "a2",
"element_type": "value",
"title": "Table 7 - Electrolyte ... | [
{
"rubric_id": "task_10-q1-01",
"q_no": 1,
"tier": "G4 Task",
"grading_mode": "match",
"kind": "retrieval",
"criterion": "States the calculated osmolarity of 1395 mOsmol/L for CLINIMIX E 5/15 based on Table 7.",
"source_type": "premise",
"source_anchor_id": "a4",
"task_types": [
... | 8 | 67 | mid | 4 | 0 | |
pharmacist/pharmacists/task_16 | pharmacist | pharmacists | Patient Counseling and Drug Information | 29a56d99-ac58-69d0-e063-6394a90a32a0 | APADAZ | 29a56d99-ac58-69d0-e063-6394a90a32a0.pdf | 18 | A pharmacist is counseling a 58-year-old patient whose physician is switching them from immediate-release hydrocodone bitartrate/acetaminophen 7.5 mg/325 mg to APADAZ for ongoing acute pain management. The pharmacist consults the APADAZ prescribing information to guide the switch and to address several issues surfaced ... | A pharmacist is counseling a 58-year-old patient whose physician is switching them from immediate-release hydrocodone bitartrate/acetaminophen 7.5 mg/325 mg to APADAZ for ongoing acute pain management. The pharmacist consults the APADAZ prescribing information to guide the switch and to address several issues surfaced ... | [
{
"q_no": 1,
"question": "For this patient starting APADAZ for acute pain, state the initial dosing instruction (number of tablets and dosing frequency) you would counsel, and cite the section of the prescribing information you used.",
"reference_answer": "Initiate at 1 to 2 tablets every 4 to 6 hours a... | [
{
"id": "a1",
"element_type": "value",
"title": "2.3 Initial Dosage",
"locator_quote": "Initiate treatment with APADAZ at 1 to 2 tablets every 4 to 6 hours",
"page": 2,
"answer_bearing": true
},
{
"id": "a2",
"element_type": "threshold",
"title": "2.3/2.5 Maximum daily tablet... | [
{
"rubric_id": "task_16-q1-01",
"q_no": 1,
"tier": "G4 Task",
"grading_mode": "match",
"kind": "retrieval",
"criterion": "Surfaces from section 2.3 Initial Dosage that APADAZ is initiated at 1 to 2 tablets every 4 to 6 hours as needed for pain.",
"source_type": "premise",
"source_anc... | 8 | 67 | hard | 1 | 0 | |
pharmacist/pharmacists/task_18 | pharmacist | pharmacists | Patient Counseling and Drug Information | 3e4b6452-1c7c-4f58-aee4-12fb185aaa83 | VELTASSA | 3e4b6452-1c7c-4f58-aee4-12fb185aaa83.pdf | 6 | An outpatient pharmacist is counseling a 15-year-old adolescent who has been newly prescribed Veltassa (patiromer) for hyperkalemia. The patient has no known drug hypersensitivities. The patient's current medication list includes levothyroxine (for thyroid replacement) and metoprolol (a beta-blocker). During counseling... | An outpatient pharmacist is counseling a 15-year-old adolescent who has been newly prescribed Veltassa (patiromer) for hyperkalemia. The patient has no known drug hypersensitivities. The patient's current medication list includes levothyroxine (for thyroid replacement) and metoprolol (a beta-blocker). During counseling... | [
{
"q_no": 1,
"question": "For this 15-year-old patient, what starting dose and what titration increment should the pharmacist recommend for initiating Veltassa, and on what basis (which population-specific labeling) is that choice made rather than the value that would apply to a different age group?",
"... | [
{
"id": "a1",
"element_type": "value",
"title": "Dosage and Administration - Adult starting dose",
"locator_quote": "the recommended starting dose of Veltassa is 8.4 grams administered orally once daily",
"page": 1,
"answer_bearing": true
},
{
"id": "a2",
"element_type": "value",... | [
{
"rubric_id": "task_18-q1-01",
"q_no": 1,
"tier": "G4 Task",
"grading_mode": "match",
"kind": "retrieval",
"criterion": "Surfaces the pediatric labeling fact that dose adjustments for patients 12 to 17 years old occur at one-week intervals.",
"source_type": "premise",
"source_anchor... | 6 | 56 | ceiling | 6 | 0 | |
pharmacist/pharmacists/task_27 | pharmacist | pharmacists | Clinical Assessment of Therapy | 4b1e2230-e7d4-470f-9ec5-99d03e80e897 | Valproate Sodium | 4b1e2230-e7d4-470f-9ec5-99d03e80e897.pdf | 20 | A hospital pharmacist reviews the medication profile of a 68-year-old woman (weight 60 kg) with new-onset complex partial seizures who is being started on valproate. The neurology team has ordered an IV valproate load followed by conversion to oral titration and asks the pharmacist to help design the initiation dose, t... | A hospital pharmacist reviews the medication profile of a 68-year-old woman (weight 60 kg) with new-onset complex partial seizures who is being started on valproate. The neurology team has ordered an IV valproate load followed by conversion to oral titration and asks the pharmacist to help design the initiation dose, t... | [
{
"q_no": 1,
"question": "Using the labeled body-weight (mg/kg) dosing parameters for complex partial seizures, calculate for this 60 kg patient the initial daily dose range and the maximum recommended daily dose, and state whether the resulting total daily doses must be administered in divided doses. Then,... | [
{
"id": "a1",
"element_type": "criteria",
"title": "Contraindications",
"locator_quote": "should not be administered to patients with hepatic disease or significant hepatic dysfunction",
"page": 3,
"answer_bearing": true
},
{
"id": "a2",
"element_type": "threshold",
"title": ... | [
{
"rubric_id": "task_27-q1-01",
"q_no": 1,
"tier": "G4 Task",
"grading_mode": "match",
"kind": "retrieval",
"criterion": "States the a4 initial dose of 10–15 mg/kg/day.",
"source_type": "premise",
"source_anchor_id": "a4",
"task_types": [
"T1"
]
},
{
"rubric_id"... | 7 | 64 | hard | 1 | 0 | |
pharmacist/pharmacy_technicians/task_10 | pharmacist | pharmacy_technicians | Prescription Intake and Verification | 4dbe9184-14cd-4666-aabf-1b7fece92337 | Fentanyl Citrate | 4dbe9184-14cd-4666-aabf-1b7fece92337.pdf | 21 | You are a pharmacy technician at an outpatient pharmacy performing intake and verification on a new e-prescription for OTFC (oral transmucosal fentanyl citrate) lozenges. Patient and prescription details:
- Patient age: 58 years
- Diagnosis: metastatic cancer with breakthrough pain
- Current opioid regimen: transdermal... | You are a pharmacy technician at an outpatient pharmacy performing intake and verification on a new e-prescription for OTFC (oral transmucosal fentanyl citrate) lozenges. Patient and prescription details:
- Patient age: 58 years
- Diagnosis: metastatic cancer with breakthrough pain
- Current opioid regimen: transdermal... | [
{
"q_no": 1,
"question": "The order specifies a per-unit strength of 600 mcg. Using the labeling section that lists the dosage forms and marketed strengths of OTFC, confirm whether 600 mcg is an available marketed strength, and state the complete list of available strengths. Cite the section you relied on."... | [
{
"id": "a1",
"element_type": "enumeration",
"title": "3 Dosage Forms and Strengths",
"locator_quote": "200 mcg, 400 mcg, 600 mcg, 800 mcg, 1200 mcg, and 1600 mcg",
"page": 3,
"answer_bearing": true
},
{
"id": "a2",
"element_type": "value",
"title": "2.3 Initial Dosage",
... | [
{
"rubric_id": "task_10-q1-01",
"q_no": 1,
"tier": "G4 Task",
"grading_mode": "match",
"kind": "retrieval",
"criterion": "Surfaces from Section 3 (Dosage Forms and Strengths) that OTFC is available in 200, 400, 600, 800, 1200, and 1600 mcg strengths (solid oral transmucosal lozenge).",
"... | 6 | 74 | easy | 5 | 0 | |
pharmacist/pharmacy_technicians/task_14 | pharmacist | pharmacy_technicians | Prescription Intake and Verification | 38c1235a-d675-4b2d-b1a5-100427af2364 | Tapentadol Hydrochloride | 38c1235a-d675-4b2d-b1a5-100427af2364.pdf | 20 | A pharmacy technician at a community pharmacy receives a new electronic prescription for NUCYNTA (tapentadol) oral solution for a 58-year-old adult. The patient has chronic moderate hepatic impairment documented as Child-Pugh score 7; renal function is normal. The e-prescription reads: '75 mg PO every 4 hours PRN pain,... | A pharmacy technician at a community pharmacy receives a new electronic prescription for NUCYNTA (tapentadol) oral solution for a 58-year-old adult. The patient has chronic moderate hepatic impairment documented as Child-Pugh score 7; renal function is normal. The e-prescription reads: '75 mg PO every 4 hours PRN pain,... | [
{
"q_no": 1,
"question": "For the ordered NUCYNTA oral solution, identify from the labeling the stated product concentration and the available fill-bottle size(s) in which the oral solution is supplied. Cite the section you used.",
"reference_answer": "The oral solution is supplied at a concentration of... | [
{
"id": "a1",
"element_type": "value",
"title": "3 Dosage Forms & Strengths",
"locator_quote": "Oral solution: 20 mg/mL in 100 mL and 200 mL fill bottles",
"page": 3,
"answer_bearing": true
},
{
"id": "a2",
"element_type": "value",
"title": "2 Concentration statement for pres... | [
{
"rubric_id": "task_14-q1-01",
"q_no": 1,
"tier": "G4 Task",
"grading_mode": "match",
"kind": "retrieval",
"criterion": "Extracts from Section 3 Dosage Forms & Strengths that the oral solution concentration is 20 mg/mL.",
"source_type": "premise",
"source_anchor_id": "a1",
"task... | 6 | 55 | mid | 4 | 4 | |
pharmacist/pharmacy_technicians/task_15 | pharmacist | pharmacy_technicians | Prescription Data Entry and Pharmacy Informatics | 758d66fb-0447-4f26-905f-595b182aebdc | RIVFLOZA | 758d66fb-0447-4f26-905f-595b182aebdc.pdf | 6 | A pharmacy technician is entering a new prescription for RIVFLOZA (nedosiran) into the pharmacy management system. The patient is 13 years old and weighs 45 kg, with a diagnosis of primary hyperoxaluria type 1. The prescription is to be given by subcutaneous injection on a once-monthly basis. During data entry the tech... | A pharmacy technician is entering a new prescription for RIVFLOZA (nedosiran) into the pharmacy management system. The patient is 13 years old and weighs 45 kg, with a diagnosis of primary hyperoxaluria type 1. The prescription is to be given by subcutaneous injection on a once-monthly basis. During data entry the tech... | [
{
"q_no": 1,
"question": "Using the product's weight- and age-based dosing information, determine the recommended per-dose amount for this patient, then identify the single available dosage-form presentation that matches that amount without leftover/wasted drug for billing.",
"reference_answer": "The 45... | [
{
"id": "a1",
"element_type": "table",
"title": "Table 1: RIVFLOZA Dose Regimen in Adults and Pediatric Patients (2 years of age and older)",
"locator_quote": "Age 2 to less than 12 years 3.3 mg/kg 128 mg 160 mg",
"page": 1,
"answer_bearing": true
},
{
"id": "a2",
"element_type":... | [
{
"rubric_id": "task_15-q1-01",
"q_no": 1,
"tier": "G4 Task",
"grading_mode": "match",
"kind": "retrieval",
"criterion": "Surfaces the dosing-table fact that a patient with body weight 39 kg to less than 50 kg at age 12 years and older receives a 128 mg dose.",
"source_type": "premise",
... | 4 | 40 | mid | 4 | 0 | |
pharmacist/pharmacy_technicians/task_20 | pharmacist | pharmacy_technicians | Patient Medication Profile Management | 8e7e5582-7a35-4ec7-85e7-b88a98d1bd23 | Contrave Extended-Release | 8e7e5582-7a35-4ec7-85e7-b88a98d1bd23.pdf | 20 | A pharmacy technician is building the medication profile for a new CONTRAVE (naltrexone 8 mg/bupropion 90 mg extended-release tablets) start ordered for a 58-year-old patient, and is reviewing the FDA label before the pharmacist verifies the order. Patient facts from the profile: documented history of a single seizure ... | A pharmacy technician is building the medication profile for a new CONTRAVE (naltrexone 8 mg/bupropion 90 mg extended-release tablets) start ordered for a 58-year-old patient, and is reviewing the FDA label before the pharmacist verifies the order. Patient facts from the profile: documented history of a single seizure ... | [
{
"q_no": 1,
"question": "Based on the patient's documented history of a single seizure episode, determine whether starting CONTRAVE is permissible for this patient per the label, and identify the exact label entry that governs this determination.",
"reference_answer": "CONTRAVE is contraindicated in th... | [
{
"id": "a1",
"element_type": "contraindication",
"title": "4 CONTRAINDICATIONS",
"locator_quote": "CONTRAVE is contraindicated in Uncontrolled hypertension",
"page": 1,
"answer_bearing": true
},
{
"id": "a2",
"element_type": "branching_rule",
"title": "4 CONTRAINDICATIONS - ... | [
{
"rubric_id": "task_20-q1-01",
"q_no": 1,
"tier": "G4 Task",
"grading_mode": "match",
"kind": "retrieval",
"criterion": "Surfaces the Contraindications entry stating that CONTRAVE is contraindicated in patients with a seizure disorder or a history of seizures.",
"source_type": "premise"... | 8 | 69 | easy | 5 | 0 | |
pharmacist/pharmacy_technicians/task_24 | pharmacist | pharmacy_technicians | Patient Medication Profile Management | 485b5018-57ec-90d7-e063-6294a90ae5e2 | Atomoxetine | 485b5018-57ec-90d7-e063-6294a90ae5e2.pdf | 16 | A pharmacy technician at a community pharmacy is building/updating the medication profile for a 62-year-old adult patient (weight 60 kg) with ADHD before the pharmacist's final verification. A new order for atomoxetine (oral capsules) has been received for this patient. The patient's current medication list, as documen... | A pharmacy technician at a community pharmacy is building/updating the medication profile for a 62-year-old adult patient (weight 60 kg) with ADHD before the pharmacist's final verification. A new order for atomoxetine (oral capsules) has been received for this patient. The patient's current medication list, as documen... | [
{
"q_no": 1,
"question": "Before reconciling this patient's medication list, catalog for the profile every condition the label identifies under its contraindications section as a reason atomoxetine must not be used, and cite the section where you found them.",
"reference_answer": "Per Section 4 (Contrai... | [
{
"id": "a1",
"element_type": "enumeration",
"title": "4 CONTRAINDICATIONS",
"locator_quote": "Hypersensitivity to atomoxetine or other constituents of product.",
"page": 2,
"answer_bearing": true
},
{
"id": "a2",
"element_type": "branching_rule",
"title": "4.2 Monoamine Oxid... | [
{
"rubric_id": "task_24-q1-01",
"q_no": 1,
"tier": "G4 Task",
"grading_mode": "match",
"kind": "retrieval",
"criterion": "Surfaces from Section 4 CONTRAINDICATIONS all five listed entries: hypersensitivity to atomoxetine or other constituents; atomoxetine use within 2 weeks after discontinui... | 5 | 52 | easy | 5 | 1 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.